Literature DB >> 15888249

HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.

F Martini1, C Agrati, G D'Offizi, F Poccia.   

Abstract

Alterations in NK cell numbers and function have been repeatedly shown during HIV infection. In this study, NK cell number and MHC class I expression on CD4+ T cells were studied in HIV patients at different stages of disease progression. An increased expression of HLA-E was seen on CD4+ T cells. In parallel, a reduced number of CD94+ NK cells was observed in advanced disease stages. Moreover, a decline in CD94 expression on NK cells was observed at the HIV replication peak in patients undergoing antiretroviral treatment interruption, suggesting a role of viral replication on NK cells alterations. In vitro HIV infection induced a rapid down-regulation of HLA-A,B,C expression, paralleled by an increased expression of HLA-E surface molecules, the formal ligands of CD94 NK receptors. HIV-infected HLA-E expressing cells were able to inhibit NK cell cytotoxicity through HLA-E expression, since cytotoxicity was restored by antibody masking experiments. These data indicate that the CD94/HLA-E interaction may contribute to NK cell dysfunction in HIV infection, suggesting a role of HIV replication in this process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888249     DOI: 10.1177/039463200501800209

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  18 in total

1.  Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B.

Authors:  Juan Wang; Yanjun Cai; Huifan Ji; Junyan Feng; Desalegn Admassu Ayana; Junqi Niu; Yanfang Jiang
Journal:  J Interferon Cytokine Res       Date:  2012-02-03       Impact factor: 2.607

Review 2.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

3.  The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.

Authors:  Alexander Hallner; Elin Bernson; Brwa Ali Hussein; Frida Ewald Sander; Mats Brune; Johan Aurelius; Anna Martner; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  Blood       Date:  2019-01-15       Impact factor: 22.113

4.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  Innate immune responses in primary HIV-1 infection.

Authors:  Persephone Borrow; Nina Bhardwaj
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

6.  Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.

Authors:  Kuldeep S Cheent; Khaleel M Jamil; Sorcha Cassidy; Mengya Liu; Berenice Mbiribindi; Arend Mulder; Frans H J Claas; Marco A Purbhoo; Salim I Khakoo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

7.  Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C.

Authors:  Juan Wang; Pingwei Zhao; Hui Guo; Xiguang Sun; Zhenyu Jiang; Lijun Xu; Junyan Feng; Junqi Niu; Yanfang Jiang
Journal:  Mediators Inflamm       Date:  2012-01-24       Impact factor: 4.711

Review 8.  The role of NK cells in HIV-1 protection: autologous, allogeneic or both?

Authors:  Jef Hens; Wim Jennes; Luc Kestens
Journal:  AIDS Res Ther       Date:  2016-03-18       Impact factor: 2.250

9.  Natural Killer Cell Diversity in Viral Infection: Why and How Much?

Authors:  Catherine A Blish
Journal:  Pathog Immun       Date:  2016

10.  Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection.

Authors:  Shu-Ling Huan; Ji-Guang Zhao; Zhen-Li Wang; Shuai Gao; Kai Wang
Journal:  BMC Infect Dis       Date:  2016-05-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.